Alterity Therapeutics Announces Presentation of Novel Biomar

MELBOURNE, Australia and SAN FRANCISCO, Nov. 27, 2023 -- Alterity Therapeutics , a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today...

Related Keywords

United States , Melbourne , Victoria , Australia , California , San Francisco , Daniel Claassen , Hannah Howlett , Paula Trujillo Diaz , David Stamler , Remy Bernarda , Nasdaq , European Commission , Company Biomarkers , Vanderbilt University Medical Center , Department Of Neurology , Research Assistant Professor , System Atrophy National Institute Of Neurological Disorders , Alterity Therapeutics , Securities Exchange , International Symposium , Multiple System Atrophy , Natural History Study , Autonomic Nervous System , Vanderbilt University Medical , Chief Executive Officer , Unified Multiple System Atrophy Rating Scale , Natural History , Parkinson Plus Syndromes , System Atrophy , Multiple System , National Institute , Neurological Disorders , Media Contacts , Securities Act , Securities Exchange Act , Annual Report , Markets ,